1 completed, 1 recruiting. 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 1 | Recruiting 1 |
Follow Cephalosporin Allergy: new trials by email Literature Review of Cephalosporin Allergy trials Research Report on Cephalosporin Allergy
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Optimizing the Diagnostic Approach to Cephalosporin Allergy Testing Beta-lactam antibiotic (cefazolin, cefuroxime, cefotaxime, ceftazidime, ceftriaxone, cefepime, pre-pen, penicillin G, ampicillin, and histamine) double-blind skin testing, Culprit cephalosporin (cefazolin, ceftazidime, ceftriaxone, cefepime, cephalexin, cefaclor, cefadroxil, cefuroxime, cefpodoxime, cefdinir, or cefixime) double-blind placebo-controlled drug challenge, Similar cephalosporin (cefepime, ceftriaxone, cefaclor, cephalexin, cefixime, or cefdinir) antibiotic double-blind placebo-controlled drug challenge - Drug Allergy, Cephalosporin Allergy | Phase 2 | Recruiting | Massachusetts General Hospital | 300 | 2025-05-05 | 2026-09-04 |
| Skin Testing and ELISPOT Assay in Patients With a History of Non-Immediate Reactions to Cephalosporins Skin tests and ELISPOT assay - Cephalosporin Allergy, Non-immediate Drug Reactions | Completed | Chulalongkorn University | 28 | 2010-06-01 | 2011-10-12 |
Drug Hypersensitivity (2) · Anaphylaxis (1) · Hypersensitivity (1)
Chemically-Induced Disorders (2) · Drug-Related Side Effects and Adverse Reactions (2) · Hypersensitivity, Immediate (1) · Immune System Diseases (1)
Ampicillin (1) · Cefaclor (1) · Cefadroxil (1) · Cefazolin (1) · Cefdinir (1) · Cefepime (1) · Cefixime (1) · Cefotaxime (1) · Cefpodoxime (1) · Ceftazidime (1) · Ceftriaxone (1) · Cefuroxime (1) · Cephalexin (1) · Enzyme-Linked Immunospot Assay (1) · Histamine (1)
Chulalongkorn University (1) · Massachusetts General Hospital (1)
Thailand (1) · United States (1)
David A Khan, MD (1) · Jettanong Klaewsongkram, MD (1) · Kimberly G Blumenthal, MD, MSc (1)
U01AI184071 (1)